Search
for
Sort by
Research 751–780 of 877
- Correlation of clinical and trichoscopy features with the degree of histologic inflammation in lichen planopilaris and frontal fibrosing alopecia in a cross-sectional study
- Cancer-Related Alopecia: From Etiologies to Global Management
- A Novel Atypical Presentation of Frontal Fibrosing Alopecia Involving the Frontoparietal Scalp
- Treatment options for alopecia areata
- Eyebrow Restoration in Deep Facial Burn: Follicular Unit Extraction Hair Transplantation after Nanofat Graft
- Differentiation of frontal fibrosing alopecia and Lichen planopilaris on trichoscopy: A comprehensive review
- Hypertrichosis, trichomegaly, and androgenic alopecia related to cetuximab treatment
- Impact of a topical lotion, CG428, on permanent chemotherapy-induced alopecia in breast cancer survivors: a pilot randomized double-blind controlled clinical trial (VOLUME RCT)
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- Duration of current alopecia areata episode predicts the effectiveness of baricitinib in Japanese patients with alopecia areata: a single-center retrospective study
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review
- SALT score distribution with ritlecitinib treatment up to 24 months in alopecia areata
- Raising awareness of Demodex mites: a neglected cause of skin disease
- Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events
- The impact, prevalence, and association of different forms of hair loss among individuals with anxiety disorder: Systematic review and meta-analysis
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Drug-induced hair pigmentation: Clinical perspectives and updates
- 51840 Efficacy of the Oral JAK1/JAK2 Inhibitor Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata: Pooled Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials
- Drug-induced scarring and permanent alopecia
- Alopecia Areata of the Nails: Diagnosis and Management
- Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1
- Janus kinase inhibitors for alopecia areata: A narrative review
- Association of resilience and perceived stress in patients with alopecia areata: A cross-sectional study
- Transdermal delivery of a new hair growth promoting solution in patients with hair loss
- Dermatologic Adverse Events from Cancer Treatments
- Hirsutism following the use of bimatoprost eyedrops for glaucoma
- Unusual loss of body hair in childhood: Trichotillomania or alopecia
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors